A breakthrough in decoding the growth process of hexagonal boron nitride (hBN), a 2D material, and its nanostructures on ...

Principal Financial Group Inc. increased its holdings in shares of Structure Therapeutics Inc. (NASDAQ:GPCR – Free Report) by 230.0% in the third quarter, according to the company in its most recent ...

an oral and biased small molecule agonist of glucagon-like-peptide-1 receptor, a validated G-protein-coupled receptors (GPCRs ...

Structure Therapeutics Inc. has selected a lead oral small ... that is being evaluated for use either alone or in combination with glucagon-like peptide-1 (GLP-1) receptor agonists.

Laboratory testing revealed his glucagon was 536pg/ml (normal ... This patient had stomatitis with congestion and edema, but bronchoscopy showed that the tissue structure of the airway below the ...

When doctors and nurses pass patient information from one shift to another -; an exchange known as a "handoff" -; the specific words they use behind closed doors matter more than they might realize.

Altimmune is entering both obesity and MASH markets with a powerful GLP-1/Glucagon dual-agonist drug called Pemvidutide, offering fat-specific weight loss and muscle preservation with a strong ...

The most extensive and thorough analysis of glucagon-like peptide-1 (GLP-1) receptor agonists has revealed significant benefits for kidney and cardiovascular outcomes in individuals with and without ...